anastomosed to renal artery trunk or branch side-to-side. All patients were treated with glucocorticoid for 3 months postoperatively, and were regularly followed up by vascular ultrasonography and aortic enhanced CT scan. Results: In this study there were 24 female and 7 male patients. The patients' age was 8-18 years. The followup time was 3-300 months. The average blood pressure was (175±26)/(100±19) mmHg before operation, and decreased to (139±15)/(85±13) mmHg after operation. SVG graft was used in 26 patients and Gore PROPATEN Vascular Graft in five patients. In SVG graft group, the graft restenosis occurred in seven patients in 1 year after surgery, and aneurysmal degeneration occurred in three patients (incidence of 10%) in 5-7 years postoperatively and was treated with endovascular exclusion; while in Gore PROPATEN Vascular Graft group there was such complications. Conclusions: Aorto-renal artery bypass is an effective treatment for Takayasu arteritis patients with severe stenosis of renal artery trunk, but using SVG graft for the bypass has a high risk of late aneurysmal degeneration of the graft. In pediatric/adolescent patients of Takayasu arteritis, the requirement for the future growth and the long-term control of disease should be considered, thus these patients could benefit more from the use of Gore PROPATEN Vascular Graft in aorto-renal artery bypass, by reducing the incidence of aneurysmal degeneration while guaranteeing the patency of the bypass graft. 
